STAT

OCTOBER 28, 2024

A person from Iowa who recently returned to the United States from West Africa has died after contracting Lassa fever, a virus that can cause Ebola-like illness in some patients. State health officials reported the case on Monday. “I want to assure Iowans that the risk of transmission is incredibly low in our state. We continue to investigate and monitor this situation and are implementing the necessary public health protocols,” Robert Kruse, state medical director of the Iowa Depa

363

363

ALiEM - Pharm Pearls

OCTOBER 28, 2024

A 2-year, 11-month-old female with a history of constipation was brought to the ED by her mother for abdominal pain. The mother noticed that the patient’s abdomen had been enlarging for months. When they visited the pediatrician several months ago, the pediatrician also noticed a mildly enlarged abdomen but the patient was asymptomatic at that time.

Chemotherapy 161

Chemotherapy Hospitals 161

STAT

OCTOBER 28, 2024

A charter company working for Charles River Laboratories, one of the largest U.S. clinical research organizations, was recently fined by Canadian authorities for improperly shipping long-tailed macaques into the country, and the flights have now prompted a probe by officials who oversee an international treaty governing endangered species. Earlier this month, the Canadian Transportation Agency fined SkyTaxi 7,500 Canadian dollars (roughly U.S. $5,400) for lacking permits to transport the primate

Drug Development 310

Drug Development 310

PharmaVoice

OCTOBER 28, 2024

As antimicrobial resistance rises, researchers are running out of time to fight each new wave of superbugs. And the funding isn’t enough.

130

130

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Communication

STAT

OCTOBER 28, 2024

Promising results from a new digital therapy could help tackle one of psychiatry’s most intractable problems — hearing voices. Auditory verbal hallucinations are one of the hallmarks of psychosis, particularly in people with schizophrenia, which affects 24 million people globally. These voices often bully or abuse the voice hearer, commenting incessantly on the person’s thoughts and behavior or even urging them to harm themself.

274

274

PharmaVoice

OCTOBER 28, 2024

Big Pharma CEOs are hedging all bets by supporting both sides of the aisle in the 2024 election.

147

147

PharmaVoice

OCTOBER 28, 2024

Digital pioneers harnessing the data to improve pharma’s outcomes.

130

130

STAT

OCTOBER 28, 2024

If one can point to anything good about the H5N1 bird flu outbreak in dairy cattle — to be honest, there’s nothing good about this situation — it’s the timing. Transmission of the virus through U.S. dairy herds took off when last winter’s flu season was effectively over, making the job of looking for people infected with H5N1 an easier task in theory, though there have been plenty of human hurdles impeding those efforts.

246

246

pharmaphorum

OCTOBER 28, 2024

Apple wins in patent infringement lawsuit with wearable maker Masimo, but fails to get the injunction on sales that it sought

95

95

STAT

OCTOBER 28, 2024

A drug used to combat fungal infections in cancer patients comes with a big caveat — research shows the medicine can last twice as long as in people with obesity. This means chemotherapies may be less effective when interacting with the medicine, but some clinicians, and their patients, are unaware of that possibility. The information, however, is not in the label because the drug — originally manufactured by Merck — was never fully tested in this population.

Chemotherapy 215

Chemotherapy Labelling 215

Advertisement

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

The Pharmacist

OCTOBER 28, 2024

Pharmacists have highlighted the cost to patients of treating scabies, as the Royal College of General Practitioners (RCGP) has reported 'regional spikes' in cases. In a statement issued on Friday (25 October), RCGP chair Professor Kamila Hawthorne said GPs were seeing scabies presentations at a rate 'above the five-year average and rising', with 'the north […] The post 'Regional spikes' in scabies reported appeared first on The Pharmacist.

72

72

STAT

OCTOBER 28, 2024

American life expectancy is falling further behind that of other wealthy countries. Many factors account for this trend, but our increasing consumption of ultra-processed food plays a major role in early and preventable deaths. U.S. agriculture subsidies encourage the production of commodity crops like corn and soybeans, which are mostly made into processed foods or used for animal feed and biofuel production.

212

212

Express Pharma

OCTOBER 28, 2024

Dr Reddy’s Laboratories announced the launch of Elobixibat, a first-in-class drug to treat chronic constipation, in India. Dr Reddy’s will market Elobixibat under the brand name BixiBat in India. The launch follows approval granted to Dr Reddy’s by the Central Drugs Standard Control Organisation (CDSCO) after submission of the company’s successful Phase-3 clinical trial to the Subject Expert Committee of the CDSCO.

70

70

STAT

OCTOBER 28, 2024

You’re reading the web version of Health Care Inc., STAT’s weekly newsletter following the flow of money in medicine.  Sign up  to get it in your inbox every Monday. What a difference a week makes Heading into last week, things were looking downright bleak for the country’s biggest health insurers. Stocks had tanked on the news that Elevance was spending more than expected on care for its Medicaid members.

Drug Development 152

Drug Development Hospitals 152

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

pharmaphorum

OCTOBER 28, 2024

Biogen has revealed encouraging phase 2 results with its anti-CD38 antibody felzartamab in rare kidney disease IgA nephropathy (IgAN), which it hopes could join a series of first-in-class therapies for the disorder.Data reported at the Kidney Week 2024 congress in San Diego showed that felzartamab was able to achieve "substantial" reductions in proteinuria and stabilised kidney function in the 54-subject IGNAZ study that extended for 18 months after the last dose of the antibody.

67

67

STAT

OCTOBER 28, 2024

Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating, because that oh-so familiar routine of deadlines, online calls, and meetings has resumed. But what can you do? The world, such as it is, continues to spin, however wobbly it may feel. So to cope, yes, we are firing up the trusty coffee kettle in brewing another cup of stimulation.

Labelling 141

Labelling Chemotherapy 141

BioPharma Dive

OCTOBER 28, 2024

Novartis follows cross-town rival Roche in partnering with Monte Rosa Therapeutics on so-called molecular glue degraders that can target “undruggable” proteins.

64

64

STAT

OCTOBER 28, 2024

This story first appeared in The Readout newsletter.  Sign up for The Readout  and receive STAT’s award-winning biotech news delivered straight to your inbox.  Hello! Today we take note of the antagonism between gene-editing players Prime Medicine and Tessera Therapeutics, consider the issue of whether the label should be updated on a Merck drug, and more.

Labelling 141

Labelling Drug Pricing Drug Development 141

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

European Pharmaceutical Review

OCTOBER 28, 2024

Phase III findings showed that TREMFYA ® (guselkumab) is the first IL-23 inhibitor to demonstrate results in subcutaneous induction and maintenance therapy of Crohn’s disease. New Phase III data from Johnson & Johnson has shown that the biologic could become the first IL-23 treatment to offer both a subcutaneous and intravenous induction regimen for the autoimmune condition.

59

59

Express Pharma

OCTOBER 28, 2024

Emcure Pharmaceuticals announces the launch of its wholly-owned subsidiary Emcutix Biopharmaceuticals set to cater to the dermatology segment in India As a part of this initiative, Emcure’s existing dermatology business will also operate under Emcutix. With a renewed focus and a dedicated team, the newly set up entity plans to expand Emcure’s offerings.

59

59

Drug Patent Watch

OCTOBER 28, 2024

The pharmaceutical industry relies heavily on Contract Development and Manufacturing Organizations (CDMOs) to streamline the drug development and manufacturing process. CDMOs provide a wide range of services that cater to the diverse needs of pharmaceutical companies, from early-stage development to commercial manufacturing.

Pharmaceutical Companies 59

Pharmaceutical Companies Pharmaceutical Companies Drug Development 59

Express Pharma

OCTOBER 28, 2024

Lupin announced its focus on formulating respiratory inhalers by incorporating a propellant with near-zero global warming potential (GWP). This initiative aims to provide patients with pressurised metered dose inhalers (pMDIs) that maintain the same efficacy and safety, while reducing their environmental impact. This is aligned to the regulations in Europe and Lupin’s commitment to reducing its carbon footprint.

59

59

Advertisement

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

pharmaphorum

OCTOBER 28, 2024

Novartis says Fabhalta shows sustained efficacy in rare disease C3G over 12 months, as it prepares for an FDA filing later this year

70

70

BioPharma Dive

OCTOBER 28, 2024

Learn why print remains a preferred channel for healthcare communications, and how printed materials can help build relationships with patients, develop brand loyalty and maintain brand consistency.

Pharmaceutical Companies 56

Pharmaceutical Companies Pharmaceutical Companies Communication 56

pharmaphorum

OCTOBER 28, 2024

In a recent pharmaphorum webinar, we sat down with Melanie Walsh, Senior Director, IBD Franchise Customer Experience and Digital Innovation, at Takeda, to learn some tips for successful content transformation.

57

57

The Guardian - Pharmaceutical Industry

OCTOBER 28, 2024

Prof Kelly Chibale says the world is failing to take advantage of African genetic diversity, and everyone could be losing out Africa has the greatest variety in human genes anywhere on the planet but the world is failing to capitalise on it, according one of the continent’s leading scientists, Prof Kelly Chibale, a man determined to change that. He believes the birthplace of humanity could hold the scientific key to its future.

60

60

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management

pharmaphorum

OCTOBER 28, 2024

Discover the latest advancements in cell therapy with the next generation of innovative treatments that are revolutionising healthcare. Explore the future of medicine today.

57

57

Compounding Pharmacy of America

OCTOBER 28, 2024

Many factors can impact male fertility or increase the risk of infertility. Learn more about using supplements and making lifestyle choices to support fertility. The post Best Supplements for Male Fertility appeared first on The Compounding Pharmacy of America.

Compounding Pharmacies 52

Compounding Pharmacies Compounding 52

PharmExec

OCTOBER 28, 2024

Collaboration seeks to advance the treatment of non-small cell lung cancer by combining Keytruda with Moderna’s novel neoantigen therapy, which has shown positive results across cancer types.

52

52

Pharmaceutical Technology

OCTOBER 28, 2024

The Pharmaceutical Automation and Digitalisation Congress (AUTOMA+) 2024 is a strategic platform for discussion and collaboration among decision makers, researchers and technologists who understand and follow this tendency.

52

52

Fuld & Company Blog

OCTOBER 28, 2024

Fuld’s webinar, AI’s Role in M&A: Accelerating Deal Success explored how artificial intelligence (AI) is transforming the M&A landscape, particularly for middle-market firms. Watch the replay Industry leaders Jeff Cruz, Managing Director at Greenwich Capital , and Shawn Flynn, Principal at Global Capital Markets , joined Alok Tayal, Managing Partner at Fuld & Company , and Nilesh Sharma, Senior Vice President at Fuld & Company , to discuss AI’s growing impact on deal proces

Process Improvement 52

Process Improvement 52